Exploring the antidepressant effects of ketamine: Insights from multimodal neuroimaging

CINP World Congress of Neuropsychopharmacology, Vienna 2018.
19.06.2018 | 09:45 – 11:30 | Austria Centre Vienna

Understanding the mechanism of action of ketamine-like drugs in mood disorders and their implementation in the clinic
Chair Dr Jennifer Phillips, The Royal's Institute of Mental Health Research, Canada
Co-Chair Prof Richard Frey, Medical University of Vienna, Austria

Speaker 1 Dr Gerard Sanacora, Yale University School of Medicine, USA,
Molecular and cellular mechanisms for the rapid-onset of antidepressant-like effects

Speaker 2 Dr Milan Scheidegger, Zürich University Hospital for Psychiatry, Switzerland,
Exploring the antidepressant effects of ketamine: Insights from multimodal neuroimaging

Speaker 3 Dr Bashkim Kadriu, National Institute of Mental Health, USA,
Behavioural, peripheral, and central nervous system biomarkers for treatment response of ketamine-like drugs

Speaker 4 Dr Jennifer Phillips, University of Ottawa Institute of Mental Health Research, Canada,
Cumulative and sustained effects of ketamine on depressive symptoms and suicidal ideation in treatment-resistant depression